About the Editorial team

Dr David Collingridge has been Editor-in-Chief of The Lancet Oncology since March 2002, and is also the Publishing Director for The Lancet’s Specialty Journals. Prior to his appointments at The Lancet, he gained a PhD in Tumour Biology from the Gray Cancer Institute/University College London, UK, and held research posts in the Department of Therapeutic Radiology, Yale University, CT, USA, and in the PET Oncology Group, Imperial College School of Medicine, Hammersmith Hospital, London, UK. Dr Collingridge has published numerous peer-review articles, editorials, opinion pieces, and news reports, and has co-authored a text book on radiobiology. He currently also holds the position of Clinical Associate Professor of Radiation Medicine at Hofstra/Northwell Health, Lake Success, NY, USA.

Dr David Collingridge can be contacted at [email protected].

Dr Ali Landman has been Deputy Editor since March, 2019. She earned her PhD in Cancer Biology from MIT, Cambridge, MA, USA, in 2009, and pursued post-doctoral research in cancer biology and neurodegenerative disease at the University of California, San Francisco, CA, USA, University College London, London, UK, and MRC Harwell, Oxford, UK, before joining The Lancet Oncology in January 2015 as a Senior Editor.

Márcia Costa is a Senior Editor at The Lancet Oncology. She studied biomedical engineering and biophysics at the University of Lisbon, followed by a PhD in cancer therapy at the Institute of Cancer Research. After a post-doctoral position at the same institute, she joined The Lancet as an Assistant Editor in 2018 and became a member of The Lancet Oncology in 2019.

Kat Gourd is a Senior Editor at The Lancet Oncology. She studied Biological Sciences at New College, University of Oxford. After graduating in 2008, she began her career in medical publishing at Future Science Group, where she worked on and subsequently managed a portfolio of review journals. She joined the Lancet family as an Assistant Editor in 2012, before joining The Lancet Oncology editorial team in 2016.

Cheryl Lai is a Senior Editor at The Lancet Oncology. After completing a PhD in Immunology at Imperial College London, she gained publishing experience as a Freelance Editorial Assistant at European Journal of Immunology and as a Commissioning Editor at Expert Opinion journals. She joined The Lancet as an Assistant Editor in 2015, and has been a member of The Lancet Oncology team since 2018.

Dr Cheryl Reeves joined The Lancet Oncology as a Senior Editor in March 2020. She earned her PhD in the Multiple Sclerosis Laboratory, University College London (UCL), Institute of Neurology, London, UK. She has since held postdoctoral research posts at UCL and Imperial College Faculty of Medicine, London, UK. Prior to joining The Lancet Oncology she was based at UCL Great Ormond Street Institute of Child Health where she worked on the genomics of paediatric brain tumours.